PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
91.94%
Positive revenue growth while ADI is negative. John Neff might see a notable competitive edge here.
122.82%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
188.14%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
188.14%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
560.71%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
589.13%
EPS growth above 1.5x ADI's 17.02%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
589.13%
Diluted EPS growth above 1.5x ADI's 6.38%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.32%
Share change of 0.32% while ADI is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.74%
Diluted share change of 3.74% while ADI is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-0.32%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-54.39%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-88.70%
Negative FCF growth while ADI is at 169.01%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
43.31%
10Y revenue/share CAGR under 50% of ADI's 102.33%. Michael Burry would suspect a lasting competitive disadvantage.
-15.35%
Negative 5Y CAGR while ADI stands at 34.26%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-11.62%
Negative 3Y CAGR while ADI stands at 5.02%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
2204.86%
5Y OCF/share CAGR above 1.5x ADI's 588.02%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-32.61%
Negative 3Y OCF/share CAGR while ADI stands at 43.37%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
39.09%
10Y net income/share CAGR of 39.09% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
104.35%
Below 50% of ADI's 2465.79%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-7.92%
Negative 3Y CAGR while ADI is 66.83%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
40.90%
5Y equity/share CAGR at 75-90% of ADI's 54.24%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
63.10%
3Y equity/share CAGR above 1.5x ADI's 31.27%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
101.36%
Dividend/share CAGR of 101.36% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-22.01%
Negative 5Y dividend/share CAGR while ADI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
80.04%
3Y dividend/share CAGR of 80.04% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.56%
Firm’s AR is declining while ADI shows 0.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-5.69%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.04%
Negative asset growth while ADI invests at 1.90%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.01%
50-75% of ADI's 5.01%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
20.71%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
8.55%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.